Sequana Medical NV (EBR:SEQUA)
Belgium · Delayed Price · Currency is EUR 0.6110
0.00 (0.00%)
Apr 28, 2026, 5:35 PM CET
Sequana Medical NV Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -51.85 | -44.65 | -32.56 | -30.76 | -23.62 | -19.11 |
Depreciation & Amortization | 1.05 | 0.62 | 0.66 | 0.31 | 0.41 | 0.31 |
Stock-Based Compensation | 0.19 | -0.18 | 0.56 | 0.56 | 0.54 | 0.26 |
Other Adjustments | 34.59 | 26.48 | 3.69 | 2.21 | 0.97 | 1.18 |
Change in Receivables | 0.17 | 0.59 | -0.54 | -0.46 | -0.16 | 0.38 |
Changes in Inventories | -0.32 | 0.21 | 0.48 | 0.04 | -0.86 | 0.13 |
Changes in Accounts Payable | -0.88 | -2.95 | -0.91 | 0.99 | -0.66 | -0.12 |
Changes in Income Taxes Payable | -0.57 | -0.37 | -0.45 | -0.38 | -0.22 | -0.04 |
Operating Cash Flow | -17.63 | -20.26 | -29.06 | -27.48 | -23.62 | -17.01 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Capital Expenditures | -0.07 | -0.1 | -0.71 | -0.68 | -0.33 | -0.14 |
Purchases of Investments | -0 | -0 | -0.01 | 0.02 | -0.01 | -0 |
Investing Cash Flow | -0.07 | -0.1 | -0.72 | -0.65 | -0.34 | -0.14 |
Financing Activities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Long-Term Debt Issued | 7.78 | 10.52 | -0.98 | 9.63 | - | 4.1 |
Long-Term Debt Repaid | -0.42 | -0.47 | -0.41 | -0.41 | -0.34 | -0.27 |
Net Long-Term Debt Issued (Repaid) | 7.36 | 10.05 | -1.4 | 9.22 | -0.34 | 3.82 |
Issuance of Common Stock | 2.99 | 11.67 | 15.79 | 28.42 | 22.77 | 19 |
Net Common Stock Issued (Repurchased) | 2.99 | 11.67 | 15.79 | 28.42 | 22.77 | 19 |
Other Financing Activities | -0.18 | -0.16 | -0.93 | -0.31 | - | -0.19 |
Financing Cash Flow | 20.85 | 21.56 | 13.46 | 37.32 | 22.44 | 22.63 |
Net Cash Flow
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Foreign Exchange Rate Adjustments | 0.01 | 0.03 | 0.03 | 0.09 | 0.1 | -0.05 |
Net Cash Flow | 3.15 | 1.2 | -16.32 | 9.19 | -1.52 | 5.48 |
Free Cash Flow
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Free Cash Flow | -17.69 | -20.35 | -29.77 | -28.16 | -23.94 | -17.14 |
Free Cash Flow Growth | - | - | - | - | - | - |
FCF Margin | - | -19292.20% | -4180.74% | -3051.80% | -6462.39% | -1779.67% |
Free Cash Flow Per Share | -0.38 | -0.55 | -1.11 | -1.24 | -1.31 | -1.12 |
Levered Free Cash Flow | -45.28 | -37.19 | -34.88 | -21.26 | -25.62 | -15.14 |
Unlevered Free Cash Flow | -18.08 | -20.93 | -30.2 | -28.16 | -24.66 | -17.78 |